|
|
|
SBA Urogyn
|
Posted by ghada S.
|
Dear Paul: please clarify this SBA
|
A |
The weekly cost of ‘no treatment’ is higher than the weekly cost of anti-cholinergic drugs |
B |
The most cost-effective treatment is solifenacin |
|
C |
The most cost-effective treatment is tolterodine extended release |
D |
The least cost-effective drug is oxybutynin immediate release |
|
E |
The drug with the worse side-effect profile is oxybutynin immediate release |
|
|
Explanation
|
Question 2 |
A 46 year old woman complains of urinary urge incontinence |
|
answer A & E is correct; as I understand from notes that oxybutynin has the worst side effects & is the most common drug to be discontinued???
|
